NCT06410092View on ClinicalTrials.gov

Study in Patients With Advanced Solid Malignancies to Evaluate the Safety of FTL001

PHASE1RecruitingINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

June 5, 2023

Primary Completion Date

January 31, 2026

Study Completion Date

March 31, 2027

Conditions
Solid Tumor
Interventions
DRUG

FTL001

IV infusion every 2 weeks

Trial Locations (3)

100021

RECRUITING

Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Beijing

400030

RECRUITING

Chongqing University Cancer Hospital, Chongqing

610041

RECRUITING

West China Hospital, Chengdu

All Listed Sponsors
lead

Sound Biopharmaceuticals Ltd.

INDUSTRY